-
UPC’s Roche-Menarini preliminary injunction clarifies relationship between independent product and manufacturing method claims
Read more: UPC’s Roche-Menarini preliminary injunction clarifies relationship between independent product and manufacturing method claimsAn independent method claim cannot, without more, result in further requirements for the infringement of an independent product claim.
-
10x Genomics, Moderna, Novo Nordisk among newly confirmed speakers for Patent Litigation Europe event (pharma & tech) next month
Read more: 10x Genomics, Moderna, Novo Nordisk among newly confirmed speakers for Patent Litigation Europe event (pharma & tech) next monthEric Whitaker, Chief Legal Officer at 10x Genomics, Karen Guo, Senior Director of Patents & IP at Novo Nordisk, and Katherine Hinterberg, Senior Director of Patent Litigation at Moderna, will speak at Kisaco Researchās annual Pharma and Biotech Patent Litigation Europe in Amsterdam.
-
Optical fibre cable makerās invalidation claims were āvaliantā but āfell flatā, EWHC rules in Fujikura v. Sterlite patent infringement decision
Read more: Optical fibre cable makerās invalidation claims were āvaliantā but āfell flatā, EWHC rules in Fujikura v. Sterlite patent infringement decisionThe High Court of Justice for England & Wales has ruled that a patent asserted by Japanese electrical equipment manufacturer Fujikura is valid and has been infringed by a range of Indian rival Sterliteās fiber optic cables.
-
U.S. and Asian companies bring vast majority of major Unified Patent Court infringement cases, reflective of EU weakness in innovation
Read more: U.S. and Asian companies bring vast majority of major Unified Patent Court infringement cases, reflective of EU weakness in innovationAbout one third of the last 100 UPC infringement actions were brought by companies headquartered in a contracting member state, but most of them are small.
-
GUEST ARTICLE: Cellular SEP aggregate royalty rate for carrier network equipment
Read more: GUEST ARTICLE: Cellular SEP aggregate royalty rate for carrier network equipmentThe following article was authored by Professor John Gong of the Department of Economics of the University of International Business and Economics (Beijing). Guest articles reflect the opinions of their authors, not those of ip fray. As smartphone manufacturers like Apple, Xiaomi and OPPO have accumulated more and more standard-essential patents (SEP), making into the…
-
UPC Roundup (1 week): contempt sanctions over continued shipments; Dusseldorf LD ordered inspection at Munich trade fair; three injunctions
Read more: UPC Roundup (1 week): contempt sanctions over continued shipments; Dusseldorf LD ordered inspection at Munich trade fair; three injunctionsThis is a summary of developments in and around the Unified Patent Court (UPC) in the week since our November 30, 2025 UPC Roundup.
-
Halozyme wins Munich PI against Merck’s Keytruda SC (subcutaneous immunotherapy); meanwhile, litigators await appointment of Judge Werner’s successor
Read more: Halozyme wins Munich PI against Merck’s Keytruda SC (subcutaneous immunotherapy); meanwhile, litigators await appointment of Judge Werner’s successorOn Thursday, Halozyme obtained a preliminary injunction against Merck’s Keytruda SC.
-
UK consultation on SEP legislation closed two months ago, and they can already scrap their plans because of what has happened since
Read more: UK consultation on SEP legislation closed two months ago, and they can already scrap their plans because of what has happened sinceThe UK government gave stakeholders 12 weeks to comment on its vision of global FRAND resolution, but the following month the landscape changed.


